A live archive of receipt-bound excerpts from company earnings calls. No generated thesis, no recommendation — just the recorded language, its source coordinates, and a direct path into the ticker dossier or live Terminal.来自公司财报电话会的可追溯摘录档案。没有生成式投资结论，也没有推荐——只有原始表述、来源坐标，以及进入个股档案或实时终端的直接入口。
Start free in Terminal免费开始使用终端50 verified call records份已核验电话会记录 · 600 exact facts条精确事实 · 2026-09-07 → 2026-09-13
Browse the full archive page by page. Search on this page by ticker, period, category, or speaker; every card preview is a verbatim call excerpt.分页浏览完整档案。在本页按代码、期间、分类或发言人搜索；每张卡片预览均为电话会原文摘录。
Showing records 5377–5472 of 5581.显示第 5377–5472 条，共 5581 条。
“Turning to Commercial Metals Company's fiscal 2026 capital spending outlook, we expect to invest approximately $600 million in total, a slightly lower guide than provided in January, given the impact of the harsh winter slowing construction of Steel West Virginia.”
“Fourth quarter general and administrative expenses were $24 million, up 29% year-over-year, and $76 million for the full year, up 44% year-over-year, primarily reflecting increased third-party costs associated with our IPO initiative, higher legal expenses, and variable costs tied to customers and revenue growth.”
“As you know, our current backlog of $2.9 billion is -- it's fully committed jobs with customers and it will be translated into revenues over the next 3-plus years.”
“So firstly, what's the earnings outlook in 2026 and how to balance the investment with the cash flow and the profitability?”
“The ability to scale our revenue while tightly controlling expenses is the primary driver of our improvement in adjusted EBITDA from 2024 to 2025, and we expect that trend to continue through 2026.”
“As Jin mentioned, revenue recognition on this contract is expected to begin during 2026, where we expect to see positive impact toward our margin profile.”
“And so as commercial construction improves, generally speaking, right, volumes in a lot of these spaces will go up because commercial conditions normalize and you still have the data center growth that really we expect to continue for 5-plus years.”
“Segment operating income margin of 4.2% for the second quarter of fiscal 2026 was down 20 basis points from prior year, primarily due to volume deleverage and product mix, largely offset by selective price adjustments and cost containment initiatives.”
“Looking ahead, the fourth quarter of 2026, we expect aesthetic treatment services revenue to be between RMB 258 million and RMB 278 million, representing year-over-year growth of 171.2% to 181.3%.”
“As Helen mentioned, based on our commercial activity to date, we expect revenue for Q1 of 2026 will exceed $18 million.”
“As Helen mentioned, based on our commercial activity to date, we expect revenue for 2026 will exceed $18 million.”
“Operating income margin was 43.8%, and adjusted operating income margins increased approximately 80 basis points to 47.7% driven by increased productivity and cost discipline while increasing our investments in AI.”
“For 2025, we generated $50.7 million in revenue, representing 605% growth compared to $7.2 million in 2024 and at the high end of our previously issued guidance range.”
“We forecast that the portfolio optimization project will positively impact 2026 comp sales by 200 to 300 basis points.”
“And from a guidance perspective for the full year 2027, we expect revenue between $866,000,000 and $874,000,000, or 24% growth at the midpoint, and a non-GAAP operating profit between $58,000,000 and $62,000,000, a 7% margin at the midpoint.”
“On an adjusted basis, margin was 2.8%, down 340 basis points year over year, primarily due to a freight benefit in the prior year, targeted promotional actions to offset adverse weather in the quarter, and the impact from opening new stores.”
“The increase to the mine site AISC guidance range in 2026 versus 2025 is primarily a result of the higher gold price assumptions impacting royalty costs, increased fleet rebuild financing, increased infill and development drilling, and increased waste stripping, all of which are designed to increase gold production in 2027 and 2028.”
“We expect margins to improve as product volumes increase, particularly as our 5G chipset sales begin contributing more meaningfully to revenue later in 2026 following the commercial launch in 2025.”
“We acquired this project for $16.5 million up front, and we think this royalty on the mine plan they're putting in will be paying us comfortably in excess of $10 million a year in royalty revenue going forward.”
“Our guidance assumes a constant foreign currency exchange rate, the fiscal 2026 net interest expense of approximately $101 million, a fiscal 2026 effective tax rate of 20%, which is the same compared to our fiscal 2025, and the guide does not include the impact of any future share buybacks or significant economic disruptions or downturns.”
“Fourth quarter net sales reached over $3.26 billion bringing our total fiscal year 2025 net sales to over $12.6 billion, delivering year-over-year net sales growth of 8.1% in Q4 and 8.3% for the full year 2025, reflecting strong execution, continued share gains in a stable category environment and consistent performance across both customer growth and spend per customer.”
“Regarding our FY '28 targets, given the business momentum, expanding profitability and visibility, we believe we are on track to meet our targets for the fiscal year ending January 31, 2028, revenue of approximately $500 million and adjusted EBITDA margin of over 20%.”
“Non-GAAP adjusted net loss for the full year of 2025 was $150.8 million, or $3.22 per share, compared to non-GAAP adjusted net loss of $101.9 million or $2.58 per share for 2024.”
“BEC product sales revenue increased modestly by 0.5% year-over-year to RMB 574.5 million mainly driven by growth in Health and Nutrition category, which was partially offset by lower sales in appliance category as we continue to optimize category mix to prioritize profitability.”
“On a full year pro forma basis, we turned a 2% net sales increase into a strong 13% increase in adjusted EBITDA year-over-year, delivering $156 million in full year 2025 or an 8.2% adjusted EBITDA margin.”
“Cost of revenues for the fourth quarter of 2025 was RMB 21.0 million, USD 3.0 million, representing a year-over-year decrease of 13.6% and from RMB 24.3 million in the fourth quarter of 2024, which was mainly due to the fewer district level project deliveries for our teaching and learning SaaS offerings as a result of a new -- as a result of growing proportion of recurring revenue and the subscription model that requires fewer hardware and software deliveries.”
“This growth was driven in part by Q4 2025 bookings, which were the largest quarterly bookings in company history, reflecting strong demand for our Rapid Production Solutions and expanding adoption across defense and aerospace programs.”
“Turning to our net revenue guidance for the full year 2026, which we introduced via press release in January and reaffirmed in our earnings release today, we continue to expect full year 2026 net revenue to range from $116 million to $121 million, representing growth of approximately 13% to 17% compared to net revenue of $103.1 million for the full year 2025.”
“Full year adjusted operating profit margin increased an impressive 140 basis points to 8.6%.”
“For the full year, revenue totaled approximately $61.7 million, reflecting stronger performance in our Treatment segment and improving waste volumes across several of our treatment facilities.”
“Pharma industry revenue increased 167.8% to $33.9 million, driven by the addition of 55 net patient affordability programs launched during the past 12 months and a corresponding increase in monthly management fees, setup fees, claim processing fees and other billable services such as dynamic business rules and customer service contact center support.”
“More importantly, with the growing revenues from operations and ongoing ATM activities, we anticipate adequate cash resources to support operations at least through 2026 by which time we aim to be a fully commercial pharmaceutical company and to own a substantially larger clinical network.”
“And you're going to see revenue goes from $100,000 a month to $200,000 a month to $1 million a month to $2 million a month.”
“We will continue to target an allocation of approximately 75% to 80% of our OpEx to sales and marketing with an aim to maintain reasonably flat G&A spend period-over-period.”
“Transaction revenue was $26.7 million, up slightly from $26.3 million in Q3 on spot volumes of $11.5 billion compared to $16.4 billion in Q3.”
“As we have said before, we anticipate margin for this to be circa 40% Note that our published Flight Path 2030 figures don't include wide-ranging second life opportunities for our batteries.”
“We had gross profit of $1.3 million on that, which we're pretty pleased with given, all the R&D and all the, additional, work that we've been doing, into our systems, and trying to do our best to over-service, our customers.”
“We expect second quarter non-GAAP operating income of $290 million to $300 million, this implies a non-GAAP operating margin of 11.8% to 12.1%.”
“Our annual target assumes 2% to 4% market volume growth.”
“If we first look at the last 3 months of the year, Q4 '25, very, very strong quarter, EUR 167 million in revenue, an increase of EUR 82 million compared to Q4 '25, '24 and with the adjusted utilization of 87% cost of sales is, of course, going up with the delivered vessels.”
“We exceeded the upper end of our revenue guidance, representing approximately 20 times growth over the year.”
“Including the cash impact of capitalized costs, free cash flow in the quarter was $14,000,000 compared to $15,000,000 in the prior year quarter, and as we have noted in the past, we expect our free cash flow to continue to fluctuate from quarter to quarter given the timing of customer and vendor payments.”
“We expect our revenue shaping, cost structure and process improvement actions to be completed towards the earlier end of the 12 to 18-month post-closing time line that we articulated previously, and for the quarter that we just ended to be the low point in terms of margin impact.”
“In 2026, we expect to deliver on our catalysts: preliminary safety and PK data for ABS-201 in the first half, interim 13-week proof-of-concept hair regrowth data in the second half, and initiation of our Phase 2 endometriosis trial in Q4, subject to data and regulatory review.”
“As a result of these decisions, we ended 2025 with strong growth and commercial traction, a healthy backlog and a strong pipeline and with a dramatically strengthened balance sheet, ending the year with $94.4 million.”
“Obviously, given the fact that we are early in a market growth, we are unable to provide guidance for 2026 in numbers, but we can say a lot on what our expectation on the business delivery that will lead to revenue growth significantly in 2026 and 2027.”
“In 2025, we delivered what we set out to do: establish a strong operating foundation with industry-leading costs, strengthen our balance sheet, and take meaningful steps to de-risk our growth pipeline.”
“And after our capital expenditure, which was largely on track to guidance when you take into account some commitments that will roll over year-end, we delivered on our CapEx profile, all resulting in healthy free cash flow of $62,000,000, which was up some 483% on the prior year.”
“Revenues for the year ended December 31, 2025 were $1.2 million as compared to $28.9 million for the full year 2024.”
“Taking a closer look at customer growth, as seen on slide nine, total active customers count increased 73% in 2025.”
“We expect annual production to exceed 220,000 oz over the first 10 years, effectively doubling our current output.”
“Finally, we are excited that activities are progressing under our strategic collaboration with AstraZeneca, which has positively impacted our 2025 revenue.”
“This is the impact that we expect to see from now on, in addition to the impact that we had in the year, which was BRL 1.19 billion in the EBITDA, and then the net profit around BRL 800 million, also with a positive effect in our net profit.”
“Provisions for contingent liability this quarter increased by 343% year-over-year to RMB 1.1 billion, reflecting the growth in loan origination volume under the risk-taking model, which grew by 48% year-over-year.”
“As artificial intelligence continues to expand globally, it is driving significant growth in electricity demands, particularly from data centers and high-performance computing infrastructure.”
“As a result of these cost efficiencies, gross profit dollars grew by $6.4 million or 185% over the prior year, and gross margin grew by two percentage points from 23% to 25% year-over-year.”
“For a list and description of the risks and uncertainties that we face, please see the reports we have filed with the SEC, including in our Annual Report on Form 10-K for the full year ended December 31, 2025, that we filed today.”
“We achieved record full year revenue of $3.9 million, a 20% increase compared to 2024, driven by strong second half momentum with fourth quarter revenue of $1.5 million, representing a 92% increase over the prior year period.”
“Equipment margins in the fiscal 2026 fourth quarter continued to face pressure from softer retail demand and remaining aged inventory; however, margins have improved as inventory has returned toward healthier levels.”
“Regarding cost, interest expense was $19 million, increased by 14% from same quarter last year due to the increase in margin financing and securities lending activities.”
“For the full year, revenue grew more than 17%, driven by strong demand across our core business lines, as well as continued market share gains.”
“As we've noted earlier in the year, we expect the cost optimization and efficiency actions implemented in 2024 and 2025 to yield meaningful savings, and those efforts contributed to improving operating leverage as revenue ramped in the second half.”
“For the full year, net revenue reached RMB 2.02 billion, up 1.5% year-over-year, while net income increased 6.9% to RMB 365.6 million, and the gross margin expanded by 2.9 percentage points to 86.9%.”
“On a full-year basis, we have reaffirmed our outlook for fiscal 2026 adjusted EBITDA of $146 million to $156 million, which includes a partial-year impact of approximately $14 million from the sale-leaseback transactions.”
“Conversely, almost all of the revenue in Q4 was generated by units dispensed to customers, with 6,232 prescribed units in Q4 and $9.1 million in net product revenue.”
“With the strength of our backlog, today we are initiating full year financial guidance with revenue in the range of $3.72 billion-$3.82 billion, representing a 51% increase at the midpoint compared to 2025.”
“Higher sales and gross margin dollars more than offset the increase in operating expenses, resulting in operating income increasing $900,000 to $14,400,000 compared to $13,500,000 in 2025.”
“Importantly, roughly two-thirds of our expected 2026 revenue is already supported by contracted backlog, giving us strong visibility into our outlook.”
“When excluding the impact of the unmitigated IEPA tariffs, gross margin increased by approximately 140 basis points to 47% compared to the prior year.”
“When excluding the impact of the unmitigated I-E-E-P-A or IEEPA tariffs, gross margin increased by approximately 140 basis points to 47% compared to the prior year.”
“For some additional color, we expect our cash usage in the coming quarters to increase slightly from the fourth quarter of 2025 as we continue to invest in the critical parts of our business to support our growth objectives.”
“As a result, we expect an EPS headwind from share dilution based on a Q4 common share equivalent assumption of approximately 242 million shares, bringing our FY '26 expected average to 239 million shares.”
“We open locations in response to customer demand, and our more than 350 organic rental starts since founding, including 85 new rental locations in 2025, reflects a disciplined, repeatable organic growth playbook.”
“For the fourth quarter specifically, our annual outlook implies total sales growth of 13% to 14.5%, which includes the extra fiscal week; same-restaurant sales growth of 3.5% to 5% incorporates the strong trends we have seen through the first three weeks of March; and we expect adjusted diluted net earnings per share between $3.59 and $3.69.”
“Revenue was below guidance due to project sales delayed into 2026 and lower than expected volumes in both solar and storage.”
“Revenue is expected to be in the range of $664.9 million-$678.3 million, and we expect adjusted EBITDA margins of 20% or above.”
“Brand portfolio gross margin declined 170 basis points to 42%, primarily reflecting a 160 basis point impact from tariffs.”
“Brand Portfolio gross margin declined 170 basis points to 42%, primarily reflecting a 160 basis point impact from tariffs.”
“Customer management revenue increased by 1%.”
“Based on the strength of our fourth quarter and full-year 2025 results and the continued execution of our key strategic initiatives, we anticipate 2026 revenue in the range of $2.54 billion to $2.56 billion and adjusted EBITDA in the range of $318 million to $322 million.”
“Our Exchange Services segment already reflects the operating leverage of that architecture with near 70% EBITDA margins driven by near 0 marginal cost on incremental data and recurring revenue economics.”
“And to answer that, I have to go a few steps into 2025, where the market had a very challenging year, with industry volumes down mid- to high-single digits versus 2024, and this happened since the first quarter of the year, with the additional pressure of the increase in beef costs that somehow made us make an adjustment in our strategy.”
“On the product side, revenues was $43 million and product margin negative by 37%, reflecting timing of orders and planned facility upgrades to support upcoming launches.”
“Fourth quarter revenue were $11.8 million, up 60% year-over-year, while full year revenues reached nearly $41 million, up 28%.”
“Our Q3 guidance reflects an estimated 1% to 5% growth in local currency, including about a 1% impact from our Federal business.”
“In the fourth quarter of 2025, net income increased by 15.4% year-over-year to RMB 337.4 million, with net income margin remaining healthy at 28.7%.”
“During 2025, portfolio cash receipts and interest income to XOMA Royalty were greater than the cumulative total of cash OpEx, our Blue Owl loan obligations, and preferred dividend payments, which highlights the potential earnings power of our business model and growth potential from future pipeline assets.”
“We estimate the additional week in fiscal year 2024 contributed approximately 150 basis points to revenue growth and 20 basis points to operating margin on full-year results.”
“Net income attributable to Weibo in the fourth quarter was $66.4 million, representing a net margin of 14% compared to 23% last year, primarily due to above-mentioned impact from operating margin and income tax.”
“Total product sales reached EUR 157.9 million, in line with our guidance, and decreasing by -3.3% over 2024 or -1.3% at constant currency.”
“To summarize the financial picture on a non-GAAP ex maritime basis, Spire delivered 44% Q4 revenue growth, expanded non-GAAP gross margins by five percentage points and improved operating cash flow by 78% and enters 2026 guiding to 50% midpoint core revenue growth with a debt-free balance sheet and a path towards profitability.”
“If we assumed no change in SaaS mix relative to FY 2026, our guidance for revenue growth would be approximately 300 basis points higher, and our adjusted operating margin would be approximately 200 basis points higher.”
“I'm pleased to present Red Cat's financial performance for the fourth quarter and full year 2025, which represents a transformational period in our company's growth trajectory.”
“Our focus at all times has been quality, which was illustrated by the 2 percentage points improvement in margin and our new business profit for full year 2025 grew by 12%.”
“In particular, looking at our adjusted profitability metrics, which mainly excludes stock-based compensation expenses and the recognition of deferred tax assets, we deliver adjusted pre-tax earnings of BRL 241 million, 12.1% above the top end of the guidance for the quarter, and BRL 592 million, 11.5% above the top end of the guidance for the full year.”
“Earlier today, we issued a press release announcing business and pipeline updates and financial results for the three months and full year ended December 31, 2025.”
Try a ticker, period, category, or a call speaker.请尝试代码、期间、分类或电话会发言人。
This is a transcript-only, historically incomplete publication. Releases, filings, slides, consensus and price reaction are visibly marked as not joined; lower-evidence packets remain held instead of being inferred.这是仅基于电话会文本且历史覆盖尚不完整的发布。新闻稿、披露文件、演示材料、一致预期和股价反应均明确标注为未接入；证据不足的数据包会被暂缓，而非由推断补齐。